Jan 24, 2024 – Publications
Nature Communications Paper for Roland Schüle and team
“Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity”
The CRC 992 »Medical Epigenetics«, MEDEP, provides a translational program for epigenetic research since July 2012. Scientists from the University Freiburg Medical Centre, the University of Freiburg and the Max Planck Institute of Immunobiology and Epigenetics team up in a consortium that explores epigenetic pathways with relevance to pathological processes.